Welcome message to Pr. Andréa GENAZZANI, the new President of the European Society of Gynecology

Dear Friends and Collegues,

As President of the European Society of Gynecology (ESG), it is an honor for me to follow Prof. David Serfaty.

The Society, after the success of our last Congress in Copenhagen, is now ready to increase its visibility and presence all around Europe in collaboration with the National Societies of Gynecology and Obstetrics.

In our next Congress, the 10th Congress of the European Society of Gynecology, chaired by Prof. J.M. Foidart, which will be held in the magnificent scenario of Bruxelles from 18th to 21st September 2013 at the Square Meeting Centre, we will reconfirm our engagement in the development of the discipline in the various chapters of basic science and clinical aspects of Obstetrics and Gynecology.

The role of the European Society of Gynecology for the development of our daily practice to improve the women health and the obstetric care all around Europe, will be reconfirmed non only by our congress, but also by the organization of the Albert Netter days of the European Society of Gynecology which will be held in Capri 09th -11th October 2014

In Bruxelles we will have the General Assembly of the ESG, where all of you are invited to discuss and to offer proposals for the development of our Society and for the improvement of the Gynecology and Obstetrics care all around Europe.

Yours sincerely,

Andrea R. Genazzani

European Medicines Agency starts safety review of Diane 35 and its generics

The European Medicines Agency’s Pharmacovigilance Risk Assessment Committee (PRAC) formally started a safety review of Diane 35 (cyproterone acetate 2 mg, ethinylestradiol 35μg), associated names and its generics at its 4-7 February 2013 meeting.

Human medicines highlights - Issue 48 - January 2013

The January 2013 issue of the European Medicines Agency's newsletter 'Human medicines highlights' is available here.

No.1 Newsletter of the ESG

Dear colleagues,
Dear Friends,
Here is the first edition of the European Society of Gynecology’s newsletter.
Thanks to the involvement of the office’s members and to the ESG board, I would like this newsletter to become not only a link between the ESG’s managers but foremost, a link between all of the ESG’s members.
This newsletter will keep you updated of the several conferences in which the ESG has taken part of. Also, the doctors Anne Grimard, Margarida Moreira and Ulysse Gaspard made a call to the member’s contribution.
The next editions will most likely talk about the excellent assessment of the ESG’s 9th congress in Copenhagen organized by Sven Olaf Skouby and by the ICS.
In the last place, this newsletter could give some professional and scientific information “flash” related to the gynecologic field.
I wish a long life and success to the ESG’s newsletter and thank those who’ll pass it through.

Dr David Serfaty
European Society Of Gynecology President

The Outcome of 770 PIP Breast Implants

Reports of an unexpectedly high early rupture rate and the use of an inappropriate gel resulted in the Poly Implant Prothese (PIP) breast implants being recalled in 2010. This medical crisis subsequently developed into an international public and political crisis. Over 500,000 PIP implants were inserted worldwide:> 45,000 in the UK, >30,000 in France.

XI WORLD CONGRESS OF PERINATAL MEDICINE

The ESG is pleased to announce the “XI WORLD CONGRESS OF PERINATAL MEDICINE”, Moscow, June 19th – 22th , 2013. You will find all the necessary information following this link. You will also find the preliminary program by clicking here